Clinical effect of promoting blood circulation and removing stasis on improving cognitive function of patients with hypertension arteriosclerosis and cerebral small vessel disease

Phase 4

Recruiting

• Conditions: Small cerebral vascular disease

• Registration Number: ITMCTR2200006595
• Lead Sponsor: The First Clinical Medical College of Beijing University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

? Outpatient or inpatient patients aged 50-80 years old and elderly residents in the community, regardless of gender, education level =6 years;
? Meet the diagnostic criteria of Western medicine and Chinese medicine;
? no history and signs of stroke;
? Willing to be randomly assigned to the test group and the control group;
? Volunteer to participate in the experiment and sign the informed consent.

Exclusion Criteria

? Patients with severe heart, liver and kidney insufficiency;
? Patients with other mental and nervous system diseases and malignant tumors;
? Participants who had participated in other drug trials within three months before enrollment;
? Poor compliance or life-threatening can not complete the course of treatment;
? Use of other cognitive-improving drugs such as ChEIs or other psychotropic drugs within the last three months.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
blood pressure;Multi-domain cognitive function scores;MMSE Score;Fazekas score;